Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.08
(-6.25%)
CAD 0.08
(-6.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.82 Million CAD | -22.72% |
| 2022 | -93.4 Million CAD | 9.08% |
| 2021 | -13.63 Million CAD | 37.88% |
| 2020 | -57.17 Million CAD | 14.91% |
| 2019 | -96.82 Million CAD | -16.94% |
| 2018 | -44.87 Million CAD | -171.08% |
| 2017 | -16.38 Million CAD | -3657.48% |
| 2016 | - CAD | -681.0% |
| 2015 | 58.32 Thousand CAD | 63.26% |
| 2014 | - CAD | -42.88% |
| 2013 | - CAD | -41.12% |
| 2012 | 1764.00 CAD | 19.6% |
| 2011 | 115.47 Thousand CAD | -3.5% |
| 2010 | 119.65 Thousand CAD | 10.08% |
| 2009 | 73.7 Thousand CAD | 436.89% |
| 2008 | -32.26 Thousand CAD | -116.68% |
| 2007 | -14.89 Thousand CAD | -100.17% |
| 2006 | 7.72 Million CAD | 41.03% |
| 2005 | 5.62 Million CAD | 106.01% |
| 2004 | 3 Million CAD | 134.26% |
| 2003 | 1.28 Million CAD | -8.2% |
| 2002 | 1.39 Million CAD | -24.44% |
| 2001 | 1.85 Million CAD | -17.16% |
| 2000 | 2.23 Million CAD | 933.16% |
| 1999 | -268.16 Thousand CAD | -30.22% |
| 1998 | -205.92 Thousand CAD | -1080.09% |
| 1997 | -17.45 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.57 Million CAD | 98.68% |
| 2024 Q2 | -1.12 Million CAD | 1321.75% |
| 2023 Q3 | -4.96 Million CAD | -124.49% |
| 2023 FY | - CAD | -22.72% |
| 2023 Q4 | -8.52 Million CAD | -71.54% |
| 2023 Q1 | -1.48 Million CAD | 73.43% |
| 2023 Q2 | -2.21 Million CAD | -48.82% |
| 2022 FY | - CAD | 9.08% |
| 2022 Q4 | -5.59 Million CAD | 30.58% |
| 2022 Q3 | -8.06 Million CAD | -88.48% |
| 2022 Q1 | -7.27 Million CAD | -20.51% |
| 2022 Q2 | -4.27 Million CAD | 41.23% |
| 2021 Q3 | -9.19 Million CAD | -61.26% |
| 2021 Q1 | -6.93 Million CAD | 46.0% |
| 2021 Q4 | -6.04 Million CAD | 34.31% |
| 2021 FY | - CAD | 37.88% |
| 2021 Q2 | -5.7 Million CAD | 17.81% |
| 2020 Q1 | -11.98 Million CAD | -5.75% |
| 2020 FY | - CAD | 14.91% |
| 2020 Q2 | -11.51 Million CAD | 3.93% |
| 2020 Q4 | -12.84 Million CAD | -54.65% |
| 2020 Q3 | -8.3 Million CAD | 27.83% |
| 2019 Q1 | -10.37 Million CAD | 5.44% |
| 2019 FY | - CAD | -16.94% |
| 2019 Q2 | -10.01 Million CAD | 3.54% |
| 2019 Q3 | -19.66 Million CAD | -96.44% |
| 2019 Q4 | -11.33 Million CAD | 42.38% |
| 2018 Q1 | -7.11 Million CAD | 19.42% |
| 2018 Q4 | -10.97 Million CAD | 29.93% |
| 2018 FY | - CAD | -171.08% |
| 2018 Q2 | -10.22 Million CAD | -43.74% |
| 2018 Q3 | -15.66 Million CAD | -53.22% |
| 2017 FY | - CAD | -3657.48% |
| 2017 Q2 | -1.54 Million CAD | -4.23% |
| 2017 Q3 | -4.74 Million CAD | -206.83% |
| 2017 Q1 | -1.48 Million CAD | -281.23% |
| 2017 Q4 | -8.82 Million CAD | -85.82% |
| 2016 Q2 | 9640.00 CAD | 111.96% |
| 2016 Q4 | -389.56 Thousand CAD | -2047.7% |
| 2016 Q1 | -80.6 Thousand CAD | -3165.8% |
| 2016 FY | - CAD | -681.0% |
| 2016 Q3 | 20 Thousand CAD | 107.48% |
| 2015 Q3 | 13.42 Thousand CAD | -41.14% |
| 2015 FY | - CAD | 63.26% |
| 2015 Q1 | 8219.00 CAD | -68.8% |
| 2015 Q2 | 22.8 Thousand CAD | 177.5% |
| 2015 Q4 | 2629.00 CAD | -80.42% |
| 2014 Q4 | 26.33 Thousand CAD | 122.29% |
| 2014 FY | - CAD | -42.88% |
| 2014 Q2 | 5818.00 CAD | 138.74% |
| 2014 Q1 | 2437.00 CAD | -82.86% |
| 2014 Q3 | 11.84 Thousand CAD | 103.66% |
| 2013 Q4 | 14.21 Thousand CAD | -30.92% |
| 2013 FY | - CAD | -41.12% |
| 2013 Q3 | 20.58 Thousand CAD | -22.1% |
| 2013 Q2 | 26.42 Thousand CAD | 31.5% |
| 2013 Q1 | 20.09 Thousand CAD | -54.37% |
| 2012 Q2 | 33.09 Thousand CAD | 8.59% |
| 2012 Q3 | 30.49 Thousand CAD | -7.86% |
| 2012 Q4 | 44.03 Thousand CAD | 44.41% |
| 2012 FY | - CAD | 19.6% |
| 2012 Q1 | 30.47 Thousand CAD | -35.11% |
| 2011 Q4 | 46.96 Thousand CAD | 89.05% |
| 2011 Q3 | 24.84 Thousand CAD | 7.08% |
| 2011 Q2 | 23.2 Thousand CAD | 13.42% |
| 2011 Q1 | 20.45 Thousand CAD | -3.97% |
| 2011 FY | - CAD | -3.5% |
| 2010 Q3 | 27.47 Thousand CAD | -39.1% |
| 2010 FY | - CAD | 10.08% |
| 2010 Q4 | 21.3 Thousand CAD | -22.46% |
| 2010 Q2 | 45.11 Thousand CAD | 74.81% |
| 2010 Q1 | 25.8 Thousand CAD | -38.12% |
| 2009 Q2 | 14.57 Thousand CAD | -13.71% |
| 2009 Q4 | 41.7 Thousand CAD | 18.2% |
| 2009 Q3 | 35.28 Thousand CAD | 142.12% |
| 2009 FY | - CAD | 436.89% |
| 2009 Q1 | 16.88 Thousand CAD | 145.49% |
| 2008 FY | - CAD | -116.68% |
| 2008 Q4 | -37.12 Thousand CAD | -254.85% |
| 2008 Q1 | -17.21 Thousand CAD | 99.7% |
| 2008 Q2 | -1905.00 CAD | 88.93% |
| 2008 Q3 | 23.97 Thousand CAD | 1358.48% |
| 2007 FY | - CAD | -100.17% |
| 2007 Q4 | -5.69 Million CAD | -317.42% |
| 2007 Q3 | 2.62 Million CAD | 70.56% |
| 2007 Q2 | 1.53 Million CAD | 0.7% |
| 2007 Q1 | 1.52 Million CAD | -66.02% |
| 2006 FY | - CAD | 41.03% |
| 2006 Q1 | 1.75 Million CAD | -41.3% |
| 2006 Q4 | 4.49 Million CAD | 416.74% |
| 2006 Q2 | 1.84 Million CAD | 5.31% |
| 2006 Q3 | 868.91 Thousand CAD | -52.87% |
| 2005 Q4 | 2.98 Million CAD | 163.42% |
| 2005 FY | - CAD | 106.01% |
| 2005 Q1 | 1.03 Million CAD | -15.3% |
| 2005 Q3 | 1.13 Million CAD | -2.8% |
| 2005 Q2 | 1.16 Million CAD | 12.8% |
| 2004 Q3 | 678.08 Thousand CAD | -7.17% |
| 2004 FY | - CAD | 134.26% |
| 2004 Q1 | 370.95 Thousand CAD | -48.66% |
| 2004 Q2 | 730.44 Thousand CAD | 96.91% |
| 2004 Q4 | 1.21 Million CAD | 79.79% |
| 2003 Q4 | 722.54 Thousand CAD | 271.84% |
| 2003 Q3 | 194.31 Thousand CAD | 120.67% |
| 2003 Q2 | 88.05 Thousand CAD | -68.42% |
| 2003 Q1 | 278.8 Thousand CAD | -81.75% |
| 2003 FY | - CAD | -8.2% |
| 2002 FY | - CAD | -24.44% |
| 2002 Q3 | -420.8 Thousand CAD | -248.51% |
| 2002 Q4 | 1.52 Million CAD | 463.03% |
| 2002 Q1 | 256.5 Thousand CAD | -87.34% |
| 2002 Q2 | 283.35 Thousand CAD | 10.47% |
| 2001 Q1 | 282.12 Thousand CAD | -88.55% |
| 2001 Q3 | -32.91 Thousand CAD | 33.01% |
| 2001 Q2 | -49.13 Thousand CAD | -117.42% |
| 2001 Q4 | 2.02 Million CAD | 6257.03% |
| 2001 FY | - CAD | -17.16% |
| 2000 Q2 | -36.83 Thousand CAD | 30.2% |
| 2000 Q1 | -52.76 Thousand CAD | 66.74% |
| 2000 FY | - CAD | 933.16% |
| 2000 Q3 | -140.74 Thousand CAD | -282.13% |
| 2000 Q4 | 2.46 Million CAD | 1851.14% |
| 1999 FY | - CAD | -30.22% |
| 1999 Q1 | -14.77 Thousand CAD | 0.0% |
| 1999 Q4 | -158.66 Thousand CAD | -422.0% |
| 1999 Q2 | -64.33 Thousand CAD | -335.51% |
| 1999 Q3 | -30.39 Thousand CAD | 52.75% |
| 1998 Q1 | -22.79 Thousand CAD | 8.29% |
| 1998 Q2 | -74.91 Thousand CAD | -228.6% |
| 1998 FY | - CAD | -1080.09% |
| 1997 FY | - CAD | 0.0% |
| 1997 Q4 | -24.85 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 152.872% |
| Avicanna Inc. | -7.35 Million CAD | -47.17% |
| Avant Brands Inc. | 4.83 Million CAD | 323.842% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 61.173% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 24155.556% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 126.469% |
| MediPharm Labs Corp. | -10.47 Million CAD | -3.312% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 94.786% |
| Canopy Growth Corporation | -312.82 Million CAD | 96.54% |
| Willow Biosciences Inc. | -11.06 Million CAD | 2.134% |